USP and Public Policy
Left
Refine Your Search
USP Global Public Policy Position published 2024
Learn More
USP Comment Letter: Submitted to The National Institutes of Health (NIH) Office of Dietary Supplements (ODS) draft CY 2025- 2029 Strategic Plan (2024). Submitted on August 20, 2024.
Learn More
USP Comment Letter Submitted to DEA on July 24, 2024 regarding schedules of Controlled Substances: Rescheduling of Marijuana (Docket No. DEA-2024-0059; A.G. Order No. 5931-2024).
Learn More
USP Comment Letter: Submitted to DEA for Schedules of Controlled Substances: Rescheduling of Marijuana; (Docket No. DEA-2024-0059; A.G. Order No. 5931-2024). Submitted on July 22, 2024.
Learn More
The USP submits comments to the Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues (“Guidance”) published by the Food and Drug Administration (…
Learn More
USP supported S. 4090, the “Dietary Supplement Listing Act of 2022.”
Learn More
USP comments to FDA on “FDA Food Safety Modernization Act: Focus on Inspections and Compliance” Docket No. FDA-2011-N-0366. Comments were submitted in 2011.
Learn More
USP comments to FDA on “Periodic Review of Existing Regulations: Retrospective Review Under E.O. 13563.” Docket No. FDA–2011–N–0259. Comments were submitted in 2019.
Learn More
USP comments to FDA on "FDA Food Safety Modernization Act: Title III--A New Paradigm for Importers. Docket Nos. FDA-2011-N-0134, FDA-2011-N-0143, FDA-2011-B-0144, FDA-2011-N-0145, and FDA-2011-N…
Learn More
USP comments to FDA for Docket no. FDA-2008-D-0381 Draft Guidance for Industry on Voluntary Third-Party Programs for Food and Feeds. Comments were submitted in 2008.
Learn More